© The Financial Times Ltd 2017 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
Anna Protopapas is a rarity in the corporate world. Not only is she one of a small number of top-ranking women in the biopharmaceutical industry, but as executive vice-president of global business development at Takeda Pharmaceuticals, she is also one of only a few women at the top of a Japanese company.
Boris Groysberg, associate professor in the organisational behaviour unit at Harvard Business School, asks some interesting questions in his new book Chasing Stars: The Myth of Talent and the Portability of Performance.
How many times, he argues, do corporations looking to hire a senior employee go outside the organisation to find a “star”, pay a premium, disrupt the status quo and leave good people disaffected, only to find the outsider fails to live up to expectations, is removed and the whole process starts again?
This blog is no longer updated but it remains open as an archive.
The 'Women at the Top' blog is part of a series of online and print publications that focuses on women's achievements in business. With up-to-date news and incisive analysis, the blog will provoke discussion on the role of the world's most prominent businesswomen. www.ft.com/womenblog
For more Women at the Top news, video interviews and other features, visit www.ft.com/womenatthetop